Brain water and acute liver failure: The emerging role of intracranial pressure monitoring

Intracranial pressure monitoring in acut

Intracranial pressure monitoring in acute liver failure. A procedure with clear indications

✍ Julia A. Wendon; Fin Stolze Larsen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 1 views

tures (etiology, hemodynamic condition, arterial ammonia, spontaneous activity of coagulation factors, serum creatinine, natremia) allowing to exclude from monitoring those patients with the highest probability of spontaneous survival. However, the best answer to the abovementioned challenge is, whe

Intracranial pressure and acute liver fa

Intracranial pressure and acute liver failure: A “finger on the pulse”

✍ John G. O'Grady 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

The encephalopathy caused by acute liver failure is secondary to metabolic change that reverses completely after spontaneous recovery or salvage with liver transplantation. However, advanced encephalopathy in some patients is also associated with physical brain injury with the potential to cause irr

Complications and use of intracranial pr

Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy

✍ Javier Vaquero; Robert J. Fontana; Anne M. Larson; Nathan M.T. Bass; Timothy J. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB

Monitoring of intracranial pressure (ICP) in acute liver failure (ALF) is controversial as a result of the reported complication risk (approximately 20%) and limited therapeutic options for intracranial hypertension. Using prospectively collected information from 332 patients with ALF and severe enc

Intracranial pressure monitoring in pati

Intracranial pressure monitoring in patients with acute liver failure: A questionable invasive surveillance

✍ Jacques Bernuau; François Durand 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Monitoring of intracranial pressure (ICP) in acute liver failure (ALF) is controversial as a result of the reported complication risk (approximately 20%) and limited therapeutic options for intracranial hypertension. Using prospectively collected information from 332 patients with ALF and severe enc

The effect of hypertonic sodium chloride

The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure

✍ Nicholas Murphy; Georg Auzinger; William Bernel; Julia Wendon 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

Acute liver failure (ALF) is a rare condition characterized by the development of encephalopathy in the absence of chronic liver disease. Cerebral edema occurs in up to 80% of patients with Grade IV encephalopathy. In the current prospective randomized controlled clinical trial, we examined the effe

Iron chelation attenuates intracranial p

Iron chelation attenuates intracranial pressure and improves survival in a swine model of acute liver failure

✍ Nikolaos Arkadopoulos; Demetrios Vlahakos; Georgia Kostopanagiotou; Dimitrios Pa 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB

Oxidative mechanisms have been implicated in the pathogenesis of brain edema in acute liver failure (ALF). The aim of this study was to test the hypothesis that inhibition of iron-catalyzed oxidative reactions through iron chelation using deferoxamine could attenuate brain edema in a swine model of